Tango Therapeutics Inc [TNGX] stock prices are down -1.97% to $7.45 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TNGX shares have gain 9.24% over the last week, with a monthly amount glided 6.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tango Therapeutics Inc [NASDAQ: TNGX] stock has seen the most recent analyst activity on August 19, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $11. Previously, Jefferies started tracking the stock with Buy rating on July 17, 2024, and set its price target to $19. On April 04, 2024, Cantor Fitzgerald initiated with a Overweight rating. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $18 on February 12, 2024. B. Riley Securities initiated its recommendation with a Buy and recommended $16 as its price target on December 08, 2023. H.C. Wainwright upgraded its rating to Buy for this stock on October 20, 2022, but kept the price target unchanged to $10. In a note dated September 20, 2021, SVB Leerink initiated an Outperform rating and provided a target price of $25 on this stock.
The stock price of Tango Therapeutics Inc [TNGX] has been fluctuating between $1.03 and $8.58 over the past year. Currently, Wall Street analysts expect the stock to reach $14.67 within the next 12 months. Tango Therapeutics Inc [NASDAQ: TNGX] shares were valued at $7.45 at the most recent close of the market. An investor can expect a potential return of 96.91% based on the average TNGX price forecast.
Analyzing the TNGX fundamentals
The Tango Therapeutics Inc [NASDAQ:TNGX] reported sales of 24.30M for trailing twelve months, representing a drop of -83.99%. Gross Profit Margin for this corporation currently stands at 0.97% with Operating Profit Margin at -6.47%, Pretax Profit Margin comes in at -5.98%, and Net Profit Margin reading is -5.99%. To continue investigating profitability, this company’s Return on Assets is posted at -0.61, Equity is -0.8 and Total Capital is -0.79. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.06 points at the first support level, and at 6.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.75, and for the 2nd resistance point, it is at 8.04.
Ratios To Look Out For
It’s worth pointing out that Tango Therapeutics Inc [NASDAQ:TNGX]’s Current Ratio is 4.75. Also, the Quick Ratio is 4.75, while the Cash Ratio stands at 0.99. Considering the valuation of this stock, the price to sales ratio is 34.11, the price to book ratio is 6.12.
Transactions by insiders
Recent insider trading involved Third Rock Ventures IV, L.P., 10% Owner, that happened on Sep 16 ’25 when 0.36 million shares were sold. 10% Owner, Third Rock Ventures IV, L.P. completed a deal on Sep 16 ’25 to buy 0.36 million shares. Meanwhile, 10% Owner Third Rock Ventures IV, L.P. sold 0.64 million shares on Sep 05 ’25.
